The Principal Secretary for the State Department for Medical Services, Dr. Ouma Oluga, held a consultative meeting with Michaelene Welsh from Wellcome Trust and Dr. George Omondi, Deputy Director of the Kenya Snakebite Research and Intervention Centre (KSRI).
During the meeting, Dr. Oluga announced the formation of a government-led committee to drive the local production of snake antivenom, an initiative spearheaded by KSRI. This initiative aims to improve access to timely and affordable treatment for snakebite victims across the country.
Dr. Omondi attended the meeting on behalf of the Director General Kenya Institute of Primate Research (KIPRE).
Distributed by APO Group on behalf of Ministry of Health, Kenya.
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
